A reminder: The real goal is saving lives

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Dear Editor,

I was disappointed to see that you reported on the results of the IMpassion 131 trial, without context. [The Cancer Letter, Sept. 4, 2020]

I often see stories touting increased funding at NCI and changes in the payline. However, these are not the ultimate goals we are all working toward. More money, more research, and more researchers are simply the tools to achieve the real goal: saving lives. Is the system set up to accomplish the real goal? I continue to question that.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Frances M. Visco, JD
President, National Breast Cancer Coalition

YOU MAY BE INTERESTED IN

When conducting a randomized clinical trial of a treatment regimen based on an immune checkpoint inhibitor, trial sponsors should include overall survival as an endpoint, FDA officials say.
Frances M. Visco, JD
President, National Breast Cancer Coalition

Login